Abbott India Limited Stock

Equities

ABBOTINDIA

INE358A01014

Pharmaceuticals

Market Closed - Bombay S.E. 03:00:39 2024-05-18 EDT 5-day change 1st Jan Change
26,644 INR 0.00% Intraday chart for Abbott India Limited +1.04% +16.59%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 58.49B 702M 958M Sales 2025 * 64.7B 777M 1.06B Capitalization 566B 6.8B 9.27B
Net income 2024 12.01B 144M 197M Net income 2025 * 13.12B 158M 215M EV / Sales 2024 9.79 x
Net cash position 2024 * 22.66B 272M 371M Net cash position 2025 * 21.47B 258M 351M EV / Sales 2025 * 8.42 x
P/E ratio 2024
47.7 x
P/E ratio 2025 *
43.1 x
Employees 3,700
Yield 2024 *
1.1%
Yield 2025 *
1.34%
Free-Float 24.52%
More Fundamentals * Assessed data
Dynamic Chart
1 week+1.04%
Current month+0.86%
1 month+1.96%
3 months-9.80%
6 months+12.98%
Current year+16.59%
More quotes
1 week
26 189.00
Extreme 26189
27 157.10
1 month
25 200.05
Extreme 25200.05
27 157.10
Current year
22 750.50
Extreme 22750.5
29 628.15
1 year
20 721.05
Extreme 20721.05
29 628.15
3 years
15 525.00
Extreme 15525
29 628.15
5 years
7 511.95
Extreme 7511.95
29 628.15
10 years
1 731.00
Extreme 1731
29 628.15
More quotes
Managers TitleAgeSince
Chief Executive Officer - 94-12-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 68 19-03-31
Chairman 81 67-12-31
Director/Board Member 67 95-12-31
More insiders
Date Price Change Volume
24-05-18 26,644 +0.58% 47
24-05-17 26,490 -0.21% 338
24-05-16 26,545 +0.42% 391
24-05-15 26,434 -1.31% 535
24-05-14 26,784 -0.96% 307

Delayed Quote Bombay S.E., May 18, 2024 at 03:00 am

More quotes
Abbott India Limited is an India-based company that is engaged in the pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolic, multi-specialty, and vaccines, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), Duvadilan (preterm labor), and others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure, Glucerna, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock Market
  2. Equities
  3. ABBOTINDIA Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW